Development of a Culturally Tailored Motivational Interviewing-Based Intervention to Improve Medication Adherence in South Asian Patients.

Development of a Culturally Tailored Motivational Interviewing-Based Intervention to Improve Medication Adherence in South Asian Patients.

and purpose: Adherence is a matter that impacts Complementary and Numerous Treatment (CAM) and conventional medicine practitioners, whereby roughly half of the victims do not take their medicines or therapies as prescribed. The session is an opportune house the place practitioners can impact affected individual adherence to remedy.

As such, evaluation was undertaken to find this in depth inside one CAM. The goal of the look at was to know the Typical Chinese language language Treatment (TCM) session course of that occurs in relation to adherence and develop a session model effectively being professionals can use.

Rabbit Polyclonal antibody Anti-CRBN
ImmunoStep
Polyclonal Goat anti-GST α-form
Detroit R&D
Polyclonal Goat anti-GST μ-form
Detroit R&D
Polyclonal Goat anti-GST p-form
Detroit R&D
UltraTek Anti-Rabbit
ScyTek Laboratories

A classical grounded thought methodology was employed to semi-structured interviews of TCM practitioners and victims along with observations of their consultations. Sampling was theoretical and by snowball within the UK.

NVivo 11 was used to assist with analysis of the transcribed interviews and observations.Seven TCM practitioners and twenty-eight victims have been recruited. TCM practitioners constructed a therapeutic relationship by way of the session by enabling victims to actually really feel comfortable, valued as individuals which built-in feeling understood and recognized, along with supported inside the administration of their effectively being. Primarily, victims needed to actually really feel cared for and have perception of their TCM practitioner for the therapeutic relationship to be established. This motivated victims to proceed with remedy.

MARK antibody
Fitzgerald
MARK antibody
Fitzgerald
MARK Antibody
SAB
MARK Antibody
SAB
MARK Antibody
Lifescience Market

The TCM Session Model for Adherence was developed to conceptualise the session course of that occurs in relation to adherence. It could be used to encourage affected individual persistence with remedy by TCM practitioners and doubtlessly completely different effectively being professionals.

Recombinant Humanp21 Recombinant Protein
ProSci
Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant)
Abbexa
Glyco Recombinant Protein A33 Recombinant Protein
ProSci
Glyco Recombinant Protein A33 Recombinant Protein
ProSci
STAG3L1 Recombinant Protein (Human) (Recombinant Tag)
ABM
Development of a Culturally Tailored Motivational Interviewing-Based Intervention to Improve Medication Adherence in South Asian Patients.
Development of a Culturally Tailored Motivational Interviewing-Based Intervention to Improve Medication Adherence in South Asian Patients.

Intention to undertake and diffuse modern ultraviolet gentle C system to regulate the expansion of microorganisms in uncooked milk amongst Thais Dairy Farmers.

This analysis goals to research the elements affecting Thai dairy farmers’ intention to make use of ultraviolet C know-how (UV-C) to scale back the variety of microorganisms in uncooked milk. The analysiser utilized the innovation and diffusion principle (IDT) and the know-how acceptance mannequin 2 (TAM2) to judge dairy farmer’s intention. The 477 dairy farmers within the central a part of Thailand had been interviewed utilizing questionnaires. The collected knowledge had been analyzed utilizing multinomial logistic regression (MLR).

Recombinant Humanp21 Recombinant Protein
92-035
Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant)
20-abx072018
Glyco Recombinant Protein A33 Recombinant Protein
96-361
Glyco Recombinant Protein A33 Recombinant Protein
96-364
STAG3L1 Recombinant Protein (Human) (Recombinant Tag)
RP030283

It was discovered that the intention to undertake UV-C can precisely predict the elements affecting the intention to make use of the know-how primarily based on the intention ranges to create diffusion and promote acceptance. To extend the diffusion and acceptance of UV-C, the perceived usefulness to extend the milk value was the most important influenced issue to advertise know-how acceptance.

EIF2B2 Antibody

1-CSB-PA007515GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against EIF2B2. Recognizes EIF2B2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

EIF2B2 Antibody

DF2254 200ul
EUR 420

EIF2B2 antibody

70R-17039 50 ul
EUR 522
Description: Rabbit polyclonal EIF2B2 antibody

EIF2B2 Antibody

44695-100ul 100ul
EUR 302.4

EIF2B2 Antibody

44695-50ul 50ul
EUR 224.4

EIF2B2 Antibody

ABD2254 100 ug
EUR 525.6

EIF2B2 siRNA

20-abx915141
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

EIF2B2 siRNA

20-abx915142
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

pOTB7-EIF2B2

PVT18433 2 ug
EUR 277.2

anti-EIF2B2

YF-PA25226 50 ul
EUR 400.8
Description: Mouse polyclonal to EIF2B2

anti-EIF2B2

YF-PA15964 50 ul
EUR 435.6
Description: Mouse polyclonal to EIF2B2

anti-EIF2B2

YF-PA15965 50 ug
EUR 435.6
Description: Mouse polyclonal to EIF2B2

anti-EIF2B2

YF-PA15966 100 ul
EUR 483.6
Description: Rabbit polyclonal to EIF2B2

anti-EIF2B2

YF-PA15967 100 ug
EUR 483.6
Description: Rabbit polyclonal to EIF2B2

EIF2B2 Rabbit pAb

A7027-100ul 100 ul
EUR 369.6

EIF2B2 Rabbit pAb

A7027-200ul 200 ul
EUR 550.8

EIF2B2 Rabbit pAb

A7027-20ul 20 ul
EUR 219.6

EIF2B2 Rabbit pAb

A7027-50ul 50 ul
EUR 267.6

EIF2B2 Blocking Peptide

DF2254-BP 1mg
EUR 234

EIF2B2 Conjugated Antibody

C44695 100ul
EUR 476.4

EIF2B2 cloning plasmid

CSB-CL007515HU1-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the EIF2B2 gene.

EIF2B2 cloning plasmid

CSB-CL007515HU2-10ug 10ug
EUR 279.6
Description: A cloning plasmid for the EIF2B2 gene.

anti- EIF2B2 antibody

FNab02694 100µg
EUR 606.3
Description: Antibody raised against EIF2B2

Anti-EIF2B2 antibody

PAab02694 100 ug
EUR 426

Anti-EIF2B2 antibody

STJ29107 100 µl
EUR 332.4
Description: This gene encodes the beta subunit of eukaryotic initiation factor-2B (EIF2B). EIF2B is involved in protein synthesis and exchanges GDP and GTP for its activation and deactivation.

Mouse EIF2B2 shRNA Plasmid

20-abx981150
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Human EIF2B2 shRNA Plasmid

20-abx955877
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

anti-EIF2B2 (5B12-E10)

LF-MA10094 100 ug
EUR 435.6
Description: Mouse monoclonal to EIF2B2

Mouse Eif2b2 ELISA KIT

ELI-47286m 96 Tests
EUR 1038

Human EIF2B2 ELISA KIT

ELI-47579h 96 Tests
EUR 988.8

Bovine EIF2B2 ELISA KIT

ELI-09623b 96 Tests
EUR 1113.6

EIF2B2 ELISA KIT|Human

EF009330 96 Tests
EUR 826.8

EIF2B2 Recombinant Protein (Mouse)

RP131216 100 ug Ask for price

EIF2B2 Recombinant Protein (Rat)

RP199304 100 ug Ask for price

EIF2B2 Recombinant Protein (Human)

RP010363 100 ug Ask for price

EIF2B2 Recombinant Protein (Human)

RP010366 100 ug Ask for price

Eif2b2 ORF Vector (Rat) (pORF)

ORF066436 1.0 ug DNA
EUR 607.2

EIF2B2 ORF Vector (Human) (pORF)

ORF003455 1.0 ug DNA
EUR 114

EIF2B2 ORF Vector (Human) (pORF)

ORF003456 1.0 ug DNA
EUR 114

Eif2b2 ORF Vector (Mouse) (pORF)

ORF043740 1.0 ug DNA
EUR 607.2

EIF2B2 sgRNA CRISPR Lentivector set (Human)

K0665601 3 x 1.0 ug
EUR 406.8

Eif2b2 sgRNA CRISPR Lentivector set (Mouse)

K3674701 3 x 1.0 ug
EUR 406.8

Eif2b2 sgRNA CRISPR Lentivector set (Rat)

K7033601 3 x 1.0 ug
EUR 406.8

EIF2B2 sgRNA CRISPR Lentivector (Human) (Target 1)

K0665602 1.0 ug DNA
EUR 184.8

EIF2B2 sgRNA CRISPR Lentivector (Human) (Target 2)

K0665603 1.0 ug DNA
EUR 184.8

EIF2B2 sgRNA CRISPR Lentivector (Human) (Target 3)

K0665604 1.0 ug DNA
EUR 184.8

Eif2b2 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3674702 1.0 ug DNA
EUR 184.8

Eif2b2 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3674703 1.0 ug DNA
EUR 184.8

Eif2b2 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3674704 1.0 ug DNA
EUR 184.8

Eif2b2 sgRNA CRISPR Lentivector (Rat) (Target 1)

K7033602 1.0 ug DNA
EUR 184.8

Eif2b2 sgRNA CRISPR Lentivector (Rat) (Target 2)

K7033603 1.0 ug DNA
EUR 184.8

Eif2b2 sgRNA CRISPR Lentivector (Rat) (Target 3)

K7033604 1.0 ug DNA
EUR 184.8

EIF2B2 Protein Vector (Human) (pPB-C-His)

PV013817 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPB-N-His)

PV013818 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPM-C-HA)

PV013819 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPM-C-His)

PV013820 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPB-C-His)

PV013821 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPB-N-His)

PV013822 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPM-C-HA)

PV013823 500 ng
EUR 394.8

EIF2B2 Protein Vector (Human) (pPM-C-His)

PV013824 500 ng
EUR 394.8

EIF2B2 Protein Vector (Mouse) (pPB-C-His)

PV174958 500 ng
EUR 723.6

EIF2B2 Protein Vector (Mouse) (pPB-N-His)

PV174959 500 ng
EUR 723.6

EIF2B2 Protein Vector (Mouse) (pPM-C-HA)

PV174960 500 ng
EUR 723.6

EIF2B2 Protein Vector (Mouse) (pPM-C-His)

PV174961 500 ng
EUR 723.6

Recombinant Human EIF2B2 Protein, GST, E.coli-100ug

QP5970-ec-100ug 100ug
EUR 685.2

Recombinant Human EIF2B2 Protein, GST, E.coli-10ug

QP5970-ec-10ug 10ug
EUR 326.4

Recombinant Human EIF2B2 Protein, GST, E.coli-1mg

QP5970-ec-1mg 1mg
EUR 2763.6

Recombinant Human EIF2B2 Protein, GST, E.coli-200ug

QP5970-ec-200ug 200ug
EUR 1077.6

Recombinant Human EIF2B2 Protein, GST, E.coli-500ug

QP5970-ec-500ug 500ug
EUR 1816.8

Recombinant Human EIF2B2 Protein, GST, E.coli-50ug

QP5970-ec-50ug 50ug
EUR 434.4

EIF2B2 Protein Vector (Rat) (pPB-C-His)

PV265742 500 ng
EUR 723.6

EIF2B2 Protein Vector (Rat) (pPB-N-His)

PV265743 500 ng
EUR 723.6

EIF2B2 Protein Vector (Rat) (pPM-C-HA)

PV265744 500 ng
EUR 723.6

EIF2B2 Protein Vector (Rat) (pPM-C-His)

PV265745 500 ng
EUR 723.6

EIF2B2 3'UTR Luciferase Stable Cell Line

TU006710 1.0 ml
EUR 1672.8

Eif2b2 3'UTR Luciferase Stable Cell Line

TU203868 1.0 ml Ask for price

Eif2b2 3'UTR GFP Stable Cell Line

TU253868 1.0 ml Ask for price

Eif2b2 3'UTR GFP Stable Cell Line

TU155700 1.0 ml Ask for price

Eif2b2 3'UTR Luciferase Stable Cell Line

TU105700 1.0 ml Ask for price

EIF2B2 3'UTR GFP Stable Cell Line

TU056710 1.0 ml
EUR 1672.8

EIF2B2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV685747 1.0 ug DNA
EUR 818.4

EIF2B2 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV685751 1.0 ug DNA
EUR 818.4

EIF2B2 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV685752 1.0 ug DNA
EUR 818.4

EIF2B2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV791527 1.0 ug DNA
EUR 379.2

EIF2B2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV791528 1.0 ug DNA
EUR 379.2

EIF2B2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

LV791529 1.0 ug DNA
EUR 379.2

EIF2B2 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)

LV791533 1.0 ug DNA
EUR 379.2

EIF2B2 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

LV791534 1.0 ug DNA
EUR 379.2

Human Translation initiation factor eIF-2B subunit beta (EIF2B2)

1-CSB-EP007515HU
  • EUR 606.00
  • EUR 318.00
  • EUR 2192.40
  • EUR 919.20
  • EUR 1461.60
  • EUR 402.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Translation initiation factor eIF-2B subunit beta(EIF2B2) expressed in E.coli

Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) Antibody

abx145205-100ug 100 ug
EUR 469.2

Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) Antibody

20-abx112366
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) Antibody

20-abx006878
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) Antibody

abx232694-100ug 100 ug
EUR 577.2

Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) Antibody

20-abx320820
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) Antibody

20-abx215100
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

EIF2B2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0665605 3 x 1.0 ug
EUR 451.2

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3674705 3 x 1.0 ug
EUR 451.2

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7033605 3 x 1.0 ug
EUR 451.2

Human Eukaryotic Translation Initiation Factor 2B Subunit Beta (EIF2B2) ELISA Kit

abx387085-96tests 96 tests
EUR 1093.2

EIF2B2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)

K0665606 1.0 ug DNA
EUR 200.4

EIF2B2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)

K0665607 1.0 ug DNA
EUR 200.4

EIF2B2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

K0665608 1.0 ug DNA
EUR 200.4

EIF2B2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV685748 1.0 ug DNA
EUR 818.4

EIF2B2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV685749 1.0 ug DNA
EUR 888

EIF2B2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV685750 1.0 ug DNA
EUR 888

EIF2B2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV791526 1.0 ug DNA
EUR 448.8

EIF2B2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)

LV791530 1.0 ug DNA
EUR 379.2

EIF2B2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

LV791531 1.0 ug DNA
EUR 448.8

EIF2B2 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)

LV791532 1.0 ug DNA
EUR 448.8

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1)

K3674706 1.0 ug DNA
EUR 200.4

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)

K3674707 1.0 ug DNA
EUR 200.4

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3)

K3674708 1.0 ug DNA
EUR 200.4

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

K7033606 1.0 ug DNA
EUR 200.4

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

K7033607 1.0 ug DNA
EUR 200.4

Eif2b2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3)

K7033608 1.0 ug DNA
EUR 200.4

Offering services for upkeep, using this innovation and reporting information about the advantages of latest know-how to create optimistic attitudes and confidence result in the unfold of know-how pushed by early adopters. The know-how builders ought to think about and design know-how suitable with current methods. Nonetheless, the collaboration of all associated events can be wanted to encourage Thai dairy farmers to strive the brand new know-how and observe the precise outcomes.

CD11b Antibody Antibody
ABD2911
ASAP1 antibody Antibody
DF8746
anti- Antibody^Polyclonal antibody control antibody
LSMab09882
Antibody
A1360-500
Anti-Glycolipid Antibody (AGA) Antibody
20-abx004855

Leave a Comment

Your email address will not be published.

Scroll to Top